ONCOS-102 (Previously CGTG-102) for Therapy of Advanced Cancers

计划入组 12 人 · 首次发布于 2012 年 5 月 15 日

An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies

计划入组 27 人 · 首次发布于 2011 年 10 月 21 日

CUE-102 in Recurrent Glioblastoma

计划入组 18 人 · 首次发布于 2025 年 4 月 9 日

LFA-102

LY-102

MG-102

EdiGene Inc.

China

NIPPON MEDICAL SCHOOL

Japan

Lederle Laboratories

United States

Lyora Therapeutics Launches With $2.5M Seed Funding to Advance Genetic Medicines for Inherited Retinal Diseases

UGN-102 Shows Durable Response in Non-Muscle Invasive Bladder Cancer Trial

LB Pharmaceuticals Advances Schizophrenia Treatment with LB-102